Cite
C2orf40 inhibits hepatocellular carcinoma through interaction with UBR5.
MLA
Wu, Yue, et al. “C2orf40 Inhibits Hepatocellular Carcinoma through Interaction with UBR5.” Journal of Gastroenterology & Hepatology, vol. 36, no. 9, Sept. 2021, pp. 2581–91. EBSCOhost, https://doi.org/10.1111/jgh.15441.
APA
Wu, Y., Xiang, Q., Lv, X., Xiang, X., Feng, Z., Tian, S., Tang, J., Xiang, T., & Gong, J. (2021). C2orf40 inhibits hepatocellular carcinoma through interaction with UBR5. Journal of Gastroenterology & Hepatology, 36(9), 2581–2591. https://doi.org/10.1111/jgh.15441
Chicago
Wu, Yue, Qin Xiang, Xiaoqin Lv, Xia Xiang, Zhihao Feng, Shaorong Tian, Jun Tang, Tingxiu Xiang, and Jianping Gong. 2021. “C2orf40 Inhibits Hepatocellular Carcinoma through Interaction with UBR5.” Journal of Gastroenterology & Hepatology 36 (9): 2581–91. doi:10.1111/jgh.15441.